IBDEI0AK ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13393,1,3,0)
 ;;=3^Neop Lymphoid,Hematopoietic & Related Tissue,Uncertain Behavior,Other
 ;;^UTILITY(U,$J,358.3,13393,1,4,0)
 ;;=4^D47.Z9
 ;;^UTILITY(U,$J,358.3,13393,2)
 ;;=^5002262
 ;;^UTILITY(U,$J,358.3,13394,0)
 ;;=D05.82^^43^624^34
 ;;^UTILITY(U,$J,358.3,13394,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13394,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Other Spec Type
 ;;^UTILITY(U,$J,358.3,13394,1,4,0)
 ;;=4^D05.82
 ;;^UTILITY(U,$J,358.3,13394,2)
 ;;=^5001934
 ;;^UTILITY(U,$J,358.3,13395,0)
 ;;=D05.81^^43^624^36
 ;;^UTILITY(U,$J,358.3,13395,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13395,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,13395,1,4,0)
 ;;=4^D05.81
 ;;^UTILITY(U,$J,358.3,13395,2)
 ;;=^5001933
 ;;^UTILITY(U,$J,358.3,13396,0)
 ;;=D05.80^^43^624^38
 ;;^UTILITY(U,$J,358.3,13396,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13396,1,3,0)
 ;;=3^Carcinoma in Situ Unspec Breast,Oth Spec Type
 ;;^UTILITY(U,$J,358.3,13396,1,4,0)
 ;;=4^D05.80
 ;;^UTILITY(U,$J,358.3,13396,2)
 ;;=^5001932
 ;;^UTILITY(U,$J,358.3,13397,0)
 ;;=D56.8^^43^624^186
 ;;^UTILITY(U,$J,358.3,13397,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13397,1,3,0)
 ;;=3^Thalassemias,Other
 ;;^UTILITY(U,$J,358.3,13397,1,4,0)
 ;;=4^D56.8
 ;;^UTILITY(U,$J,358.3,13397,2)
 ;;=^5002305
 ;;^UTILITY(U,$J,358.3,13398,0)
 ;;=C82.89^^43^624^76
 ;;^UTILITY(U,$J,358.3,13398,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13398,1,3,0)
 ;;=3^Follicular Lymphoma,Extranodal/Solid Organ Sites,Other Types
 ;;^UTILITY(U,$J,358.3,13398,1,4,0)
 ;;=4^C82.89
 ;;^UTILITY(U,$J,358.3,13398,2)
 ;;=^5001540
 ;;^UTILITY(U,$J,358.3,13399,0)
 ;;=D51.8^^43^624^193
 ;;^UTILITY(U,$J,358.3,13399,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13399,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemias,Other
 ;;^UTILITY(U,$J,358.3,13399,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,13399,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,13400,0)
 ;;=I80.9^^43^624^178
 ;;^UTILITY(U,$J,358.3,13400,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13400,1,3,0)
 ;;=3^Phlebitis/Thrombophlebitis,Unspec Site
 ;;^UTILITY(U,$J,358.3,13400,1,4,0)
 ;;=4^I80.9
 ;;^UTILITY(U,$J,358.3,13400,2)
 ;;=^93357
 ;;^UTILITY(U,$J,358.3,13401,0)
 ;;=D45.^^43^624^179
 ;;^UTILITY(U,$J,358.3,13401,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13401,1,3,0)
 ;;=3^Polycythemia Vera
 ;;^UTILITY(U,$J,358.3,13401,1,4,0)
 ;;=4^D45.
 ;;^UTILITY(U,$J,358.3,13401,2)
 ;;=^96105
 ;;^UTILITY(U,$J,358.3,13402,0)
 ;;=C77.3^^43^624^109
 ;;^UTILITY(U,$J,358.3,13402,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13402,1,3,0)
 ;;=3^Malig Neop Axilla/Upper Limb Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,13402,1,4,0)
 ;;=4^C77.3
 ;;^UTILITY(U,$J,358.3,13402,2)
 ;;=^5001330
 ;;^UTILITY(U,$J,358.3,13403,0)
 ;;=C77.2^^43^624^125
 ;;^UTILITY(U,$J,358.3,13403,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13403,1,3,0)
 ;;=3^Malig Neop Intra-Abdominal Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,13403,1,4,0)
 ;;=4^C77.2
 ;;^UTILITY(U,$J,358.3,13403,2)
 ;;=^267316
 ;;^UTILITY(U,$J,358.3,13404,0)
 ;;=C77.1^^43^624^126
 ;;^UTILITY(U,$J,358.3,13404,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13404,1,3,0)
 ;;=3^Malig Neop Intrathoracic Lymph Nodes,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,13404,1,4,0)
 ;;=4^C77.1
 ;;^UTILITY(U,$J,358.3,13404,2)
 ;;=^267315
 ;;^UTILITY(U,$J,358.3,13405,0)
 ;;=C77.0^^43^624^142
 ;;^UTILITY(U,$J,358.3,13405,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13405,1,3,0)
 ;;=3^Malig Neop Nodes of Head,Face and Neck,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,13405,1,4,0)
 ;;=4^C77.0
 ;;^UTILITY(U,$J,358.3,13405,2)
 ;;=^5001329
 ;;^UTILITY(U,$J,358.3,13406,0)
 ;;=C77.8^^43^624^143
 ;;^UTILITY(U,$J,358.3,13406,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13406,1,3,0)
 ;;=3^Malig Neop Nodes of Multiple Regions,Sec and Unspec
 ;;^UTILITY(U,$J,358.3,13406,1,4,0)
 ;;=4^C77.8
 ;;^UTILITY(U,$J,358.3,13406,2)
 ;;=^5001332
 ;;^UTILITY(U,$J,358.3,13407,0)
 ;;=C79.51^^43^624^113
 ;;^UTILITY(U,$J,358.3,13407,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13407,1,3,0)
 ;;=3^Malig Neop Bone,Secondary
 ;;^UTILITY(U,$J,358.3,13407,1,4,0)
 ;;=4^C79.51
 ;;^UTILITY(U,$J,358.3,13407,2)
 ;;=^5001350
 ;;^UTILITY(U,$J,358.3,13408,0)
 ;;=C79.52^^43^624^112
 ;;^UTILITY(U,$J,358.3,13408,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13408,1,3,0)
 ;;=3^Malig Neop Bone Marrow,Secondary
 ;;^UTILITY(U,$J,358.3,13408,1,4,0)
 ;;=4^C79.52
 ;;^UTILITY(U,$J,358.3,13408,2)
 ;;=^5001351
 ;;^UTILITY(U,$J,358.3,13409,0)
 ;;=C79.31^^43^624^114
 ;;^UTILITY(U,$J,358.3,13409,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13409,1,3,0)
 ;;=3^Malig Neop Brain,Secondary
 ;;^UTILITY(U,$J,358.3,13409,1,4,0)
 ;;=4^C79.31
 ;;^UTILITY(U,$J,358.3,13409,2)
 ;;=^5001347
 ;;^UTILITY(U,$J,358.3,13410,0)
 ;;=C79.72^^43^624^129
 ;;^UTILITY(U,$J,358.3,13410,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13410,1,3,0)
 ;;=3^Malig Neop Left Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,13410,1,4,0)
 ;;=4^C79.72
 ;;^UTILITY(U,$J,358.3,13410,2)
 ;;=^5001357
 ;;^UTILITY(U,$J,358.3,13411,0)
 ;;=C78.02^^43^624^133
 ;;^UTILITY(U,$J,358.3,13411,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13411,1,3,0)
 ;;=3^Malig Neop Left Lung,Secondary
 ;;^UTILITY(U,$J,358.3,13411,1,4,0)
 ;;=4^C78.02
 ;;^UTILITY(U,$J,358.3,13411,2)
 ;;=^5001336
 ;;^UTILITY(U,$J,358.3,13412,0)
 ;;=C78.7^^43^624^138
 ;;^UTILITY(U,$J,358.3,13412,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13412,1,3,0)
 ;;=3^Malig Neop Liver/Intrahepatic Bile Duct,Secondary
 ;;^UTILITY(U,$J,358.3,13412,1,4,0)
 ;;=4^C78.7
 ;;^UTILITY(U,$J,358.3,13412,2)
 ;;=^5001339
 ;;^UTILITY(U,$J,358.3,13413,0)
 ;;=C79.71^^43^624^151
 ;;^UTILITY(U,$J,358.3,13413,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13413,1,3,0)
 ;;=3^Malig Neop Right Adrenal Gland,Secondary
 ;;^UTILITY(U,$J,358.3,13413,1,4,0)
 ;;=4^C79.71
 ;;^UTILITY(U,$J,358.3,13413,2)
 ;;=^5001356
 ;;^UTILITY(U,$J,358.3,13414,0)
 ;;=C78.01^^43^624^155
 ;;^UTILITY(U,$J,358.3,13414,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13414,1,3,0)
 ;;=3^Malig Neop Right Lung,Secondary
 ;;^UTILITY(U,$J,358.3,13414,1,4,0)
 ;;=4^C78.01
 ;;^UTILITY(U,$J,358.3,13414,2)
 ;;=^5001335
 ;;^UTILITY(U,$J,358.3,13415,0)
 ;;=C79.70^^43^624^106
 ;;^UTILITY(U,$J,358.3,13415,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13415,1,3,0)
 ;;=3^Malig Neop Adrenal Gland Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,13415,1,4,0)
 ;;=4^C79.70
 ;;^UTILITY(U,$J,358.3,13415,2)
 ;;=^5001355
 ;;^UTILITY(U,$J,358.3,13416,0)
 ;;=C78.00^^43^624^139
 ;;^UTILITY(U,$J,358.3,13416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13416,1,3,0)
 ;;=3^Malig Neop Lung Unspec,Secondary
 ;;^UTILITY(U,$J,358.3,13416,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,13416,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,13417,0)
 ;;=D57.1^^43^624^182
 ;;^UTILITY(U,$J,358.3,13417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13417,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,13417,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,13417,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,13418,0)
 ;;=D75.1^^43^624^180
 ;;^UTILITY(U,$J,358.3,13418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13418,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,13418,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,13418,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,13419,0)
 ;;=C90.30^^43^624^183
 ;;^UTILITY(U,$J,358.3,13419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13419,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,13419,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,13419,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,13420,0)
 ;;=D56.3^^43^624^184
 ;;^UTILITY(U,$J,358.3,13420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13420,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,13420,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,13420,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,13421,0)
 ;;=D56.9^^43^624^185
 ;;^UTILITY(U,$J,358.3,13421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13421,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,13421,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,13421,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,13422,0)
 ;;=M31.1^^43^624^187
 ;;^UTILITY(U,$J,358.3,13422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13422,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,13422,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,13422,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,13423,0)
 ;;=D51.2^^43^624^188
 ;;^UTILITY(U,$J,358.3,13423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13423,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,13423,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,13423,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,13424,0)
 ;;=D05.92^^43^624^35
 ;;^UTILITY(U,$J,358.3,13424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13424,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,13424,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,13424,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,13425,0)
 ;;=D05.91^^43^624^37
 ;;^UTILITY(U,$J,358.3,13425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13425,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,13425,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,13425,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,13426,0)
 ;;=D05.90^^43^624^33
 ;;^UTILITY(U,$J,358.3,13426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13426,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,13426,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,13426,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,13427,0)
 ;;=D51.0^^43^624^189
 ;;^UTILITY(U,$J,358.3,13427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13427,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,13427,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,13427,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,13428,0)
 ;;=D51.1^^43^624^190
 ;;^UTILITY(U,$J,358.3,13428,1,0)
 ;;=^358.31IA^4^2
